UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003528
Receipt number R000004281
Scientific Title The efficacy and safety of Kampo (Japanese herbal) medicine, bofutsushosan, on matabolic syndrome -a randomized, double-blind, placebo-controlled trial-
Date of disclosure of the study information 2010/04/24
Last modified on 2013/04/25 18:46:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The efficacy and safety of Kampo (Japanese herbal) medicine, bofutsushosan, on matabolic syndrome -a randomized, double-blind, placebo-controlled trial-

Acronym

The efficacy and safety of bofutsushosan on matabolic syndrome

Scientific Title

The efficacy and safety of Kampo (Japanese herbal) medicine, bofutsushosan, on matabolic syndrome -a randomized, double-blind, placebo-controlled trial-

Scientific Title:Acronym

The efficacy and safety of bofutsushosan on matabolic syndrome

Region

Japan


Condition

Condition

metabolic syndrome

Classification by specialty

Medicine in general Cardiology Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine whether bofutsushosan is useful for metabolic syndrome and which condition affects its usefulness from the viewpoint of Kampo medicine

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

body weight after 6-month administration

Key secondary outcomes

abdominal circumference, blood pressure, HDL, LDL, TG, HbA1c, FBS, HOMA-IR, hs-CRP, CAVI, S100A12, adiponectin, TNF-alfa, and SF-36 after 6-month administration and adverse events during the test period


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

27 extract tablets of bofutsushosan manufactured by Kracie Pharmaceutical Ltd. per day, in 3 divided doses before or between meals, during 6 months

Interventions/Control_2

27 placebo tablets per day, in 3 divided doses before or between meals, during 6 months

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Both A and B are required
A: abdominal circumference: 85 cm or over in men and 90 cm or over in women
B: one or more requirements below shold be met
1.[TG: 150mg/dl or over] and/or [HDL 40mg/dl or over]
2.[systolic blood pressure: 130mmHg or over] and/or [diastorlic blood pressure: 85mmHg or over]
3.fasting blood glucose: 110mg/dl or over

Key exclusion criteria

1.those who are taking Kampo drugs
2.those who have taken Kampo drugs in the past 4 weeks
3.those who need the treatment by conventional medicine
4.those who present significant liver or renal dysfunction
5.those who are taking the drugs affecting abdominal circumference or body weight
6.those who are taking antihyperlipidemic agents, antihypertensive agents, or antihyperglycemic agents
7.those with malignancy or heart failure which affects their general condition
8.those judged unsuitable for the trial by physician-in-charge

Target sample size

180


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroshi Odaguchi

Organization

Oriental Medicine Research Center, Kitasato University

Division name

Center for Evidence-Based Medicine

Zip code


Address

5-9-1, Shirokane, Minatoku, Tokyo

TEL

03-3444-6161

Email



Public contact

Name of contact person

1st name
Middle name
Last name Hiroshi Odaguchi

Organization

Oriental Medicine Research Center, Kitasato University

Division name

Center for Evidence-Based Medicine

Zip code


Address

5-9-1, Shirokane, Minatoku, Tokyo

TEL

03-3444-6161

Homepage URL


Email



Sponsor or person

Institute

Oriental Medicine Research Center, Kitasato University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北里大学東洋医学総合研究所


Other administrative information

Date of disclosure of the study information

2010 Year 04 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 12 Month 19 Day

Date of IRB


Anticipated trial start date

2010 Year 03 Month 01 Day

Last follow-up date

2013 Year 03 Month 31 Day

Date of closure to data entry

2013 Year 06 Month 15 Day

Date trial data considered complete

2013 Year 07 Month 15 Day

Date analysis concluded

2013 Year 10 Month 31 Day


Other

Other related information



Management information

Registered date

2010 Year 04 Month 24 Day

Last modified on

2013 Year 04 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004281


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name